The “Mad Men” behind the Draper Sterling firm that got $35,000 from Donald Trump’s presidential campaign are reportedly also the co-founders of medical device company XenoTherapeutics. Campaign finance documents released this week showed that the Trump campaign paid $35,000 to Londonderry, N.H.-based Draper Sterling; the name is a play on the names of 2 characters on […]
Regenerative Medicine
CorMatrix launches Tyke cardiac tissue repair device for neonates
CorMatrix Cardiovascular said today it launched its CorMatrix Tyke cardiac tissue repair patch designed for correcting congenital heart defects in neonates and infants, touting the 1st successful procedures utilizing the patch. The CorMatrix Tyke is a patch designed to repair pericardial structures and as an epicardial covering or for intracardiac defects, septal defects, annulus repair, suture-line […]
BioTime announces new funding round
BioTime yesterday announced a new offering of shares to support the development and commercialization of its regenerative medicine technologies. BioTime and its subsidiaries develop regenerative technologies around pluripotent stem cells and cell-based therapies. Oppenheimer & Co will act as sole book-running manager for the offering, according to a press release. The company has not yet stated […]
BioTime subsidiary wins $2m grant for regenerative dry-AMD treatment
Regenerative medicine company BioTime said today its subsidiary Cell Cure Neurosciences won a $2.2 million (ILS ₪8.4 million) grant from the Israel Innovation Authority of the Ministry of Economy and Industry. The grant will support the continued development of its cell-based therapeutic OpRegen, designed to treat severe stages of the dry form of age-related macular degeneration, a leading […]
Study shows no increased cancer risk with Medtronic’s InFuse
A study of nearly 17,000 patients who had spine fusion procedures showed no increased cancer risk with the InFuse bone-growth protein made by Medtronic (NYSE:MDT). The retrospective cohort study, published online last week in the journal Spine, used data from the Washington State Comprehensive Hospital Abstract Reporting System, the Washington State Cancer Registry and death certificates from […]
Avita Medical signs Malaysian distro deal with Mintcare
Avita Medical (ASX:AVH) said today it inked a distribution deal with Asia-Pacific specialized wound care product distributor Mintcare. Through the deal, Mintcare will distribute Avita’s wound care products throughout the Asia-Pacific region, with an initial focus on Malaysia, U.K.-based Avita Medical said. “The deal with Mintcare will give Avita Medical an active presence to deliver […]
StemCells to wind down operations after ending mid-stage study
(Reuters) – StemCells Inc said it would wind down operations after the company terminated a mid-stage trial testing its therapy in spinal cord injury, sending its shares plummeting 85%. The magnitude of the treatment’s effect did not justify continuing the study given the financial resources available, StemCells said on Tuesday. The Newark, California-based biotech said […]
Israeli firms team up for high-speed 3D stem cell printing
(Reuters) – Israeli 3D printer firm Nano Dimension has successfully lab-tested a 3D bioprinter for stem cells, paving the way for the potential printing of large tissues and organs, the company said on Wednesday. While 3D printers are used already to create stem cells for research, Nano Dimension said the trial, conducted with Israeli biotech firm […]
NuVasive launches Attrax bone putty in the U.S.
NuVasive Inc. (NSDQ:NUVA) said today that it’s launching its Attrax bone putty in the U.S., after winning 510(k) clearance from the FDA in October 2015. The synthetic bone graft putty is designed to encourage bone growth at the site of a spinal fusion procedure. “We are excited to officially launch Attrax putty for surgical use in […]
Medtronic: Infuse data delay was inadvertent
Medtronic (NYSE:MDT) reportedly said this week that its years-long delay in releasing adverse event data for its controversial Infuse bone-growth protein was inadvertent. The Minneapolis Star Tribune last month reported that a 2-year Medtronic review of some 3,647 Infuse patients in 2008 turned up about 1,000 adverse events that weren’t reported to the FDA until 2013. That prompted Sens. Al Franken […]
Biostage unveils $5 million offering for organ regeneration tech
Organ regeneration specialist Biostage (NSDQ:BSTG), formerly know as Harvard Apparatus Regenerative Technology, announced that it will offer $5 million worth of common stock May 19 to fund its ongoing R&D efforts. BSTG shares closed down -3.5% at $1.65 apiece yesterday on the news. The offering comes on the heels of word that the Holliston, Mass.-based company […]